The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
A bipartisan group of state health policymakers from both the executive and legislative branches who are focused on improving population health.
Networks of state officials, advocates, and others aiming to invest in and transform primary care.
A program dedicated to advancing state-based efforts to make health care more affordable for residents, employers, and states.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
A leadership development program for early and mid-career state government officials who are committed to improving the health of all people in their communities.
A leadership program for senior state government officials who are committed to improving population health.
The Fund focuses on creating an affordable health care system built on strong primary care and partnerships that improve health outcomes for all.
Improving state leaders’ ability to enact and implement evidence-based health policies.
Advancing policies that create a more prevention- and primary care-oriented health system.
Improving population health through policies that contain health care cost growth.
Our state health policy resources offer relevant data analysis and best practices.
The Fund publishes reports, issues briefs, and case studies on state health policy issues.
Short takes on health policy issues from Milbank staff and guest authors.
Insights from Milbank President Debra Lubar on state health policymaking.
Reported articles and Q&As on timely health policy issues, as well as foundation updates.
Milbank Memorial Fund and Milbank Quarterly webinars featuring state health policymakers and researchers.
Updates and expert contact information for reporters.
The Milbank Memorial Fund is a private foundation that works to improve population health and health equity.
Alan B. Cohen,
As this issue of the Quarterly goes to press, the global struggle with COVID-19 is midway through its second year. Infection rates are surging once… More
Rebecca C.H. Brown, Kamal Mahtani, Amadea Turk, Stephanie Tierney,
Social prescribing is an effort to recognize and address the broader, nonclinical contributors to health and well-being made by social and economic factors, while maintaining the clinical role of medically trained staff. More
George Maliha, Sara Gerke, I. Glenn Cohen, Ravi B. Parikh,
After more than a decade of promise and hype, artificial intelligence (AI) and machine learning (ML) are finally making inroads into clinical… More
Frank J. Thompson, Jennifer Farnham, Emmy Tiderington, Michael K. Gusmano, Joel C. Cantor,
Context: The Affordable Care Act extended Medicaid eligibility to large numbers of individuals experiencing or at risk of homelessness. This… More
Rachel E. Fabi, Brendan Saloner, Holly Taylor,
Context: Even though nearly 6% of citizen babies born in the United States have at least one undocumented parent, undocumented immigrants are… More
Benjamin J. McMichael,
Context: As many parts of the United States continue to face physician shortages, the increased use of nurse practitioners (NPs) can improve access to… More
Margo G. Wootan, Angela Amico, Michael F. Jacobson, Cindy Leung, Walter Willett,
This article describes a strategic combination of research, advocacy, corporate campaigns, communications, grassroots mobilization, legislation, regulatory actions, and litigation against companies and government to secure a national policy to remove artificial trans fat from the US food system. More
F. Reed Johnson, Juan Marcos Gonzalez, Jui-Chen Yang, Semra Ozdemir, Steven Kymes,
Context: The direct and indirect impacts of serious mental illness (SMI) on health care systems and communities represents a significant burden.… More
Jonathan Purtle, Rennie Joshi, Félice Lê-Scherban, Rosie Mae Henson, Ana V. Diez Roux,
Context: A substantive body of research has explored what factors influence elected officials’ opinions about health issues. However, no studies… More
Richard G. Frank, Thomas G. McGuire, Ian Nason,
Context: The image of generic drugs as a commodity sold in competitive markets is an oversimplification, as evidenced by increasing accounts of price… More
Previous issue
June 2021
Next issue
December 2021